Delivery Order SPE2DR25D6028-SPE2DR26FASSJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This competitive, non-set-aside delivery order carries a firm fixed price ceiling value of $95,683.36 with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Department of Defense awarded a $23,920.80 delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of DARZALEX FASPR 1800 1S pharmaceutical products. This firm fixed-price delivery order, with an ultimate completion date of October 8, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA). The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $5,980.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on October 31, 2025, with completion targeted for November 24, 2025. The order covers DARZALEX FASPRO 1,800mg-30,000 15ml units and represents a non-set-aside, competitively awarded contract. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries...
- The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $75,626.52 to AmerisourceBergen Drug Corp for supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $126,044.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order issued without a set-aside designation, reflecting competitive procurement practices. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $6,747.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of DARZALEX 400 mg/20 ml vials. The contract, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location at the same address. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,940.60 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued on October 27, 2025, with an ultimate completion date of November 18, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, valued at $11,960.40. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 26, 2025. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order is...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASSJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $63,022.10 for DARZALEX FASPR 1800 1S on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for the Department of Defense. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a broad range of medical commodities to federal agencies through this prime contract vehicle, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. The company's established federal procurement relationships with the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems demonstrate its capability to meet defense medical supply requirements. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, and AmerisourceBergen is positioned as a key vendor for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.0k | 12/11/25 |